Rolta has denied the report from Glaucus Research which indicated fabrication of the reported capital expenditures in order to mask their materially overstated EBITDA. But Amit Tandon, MD of Institutional Investor Advisory Services is not convinced and says just a denial of charges by the company is not good enough.
first published: Apr 17, 2015 11:50 am
A collection of the most-viewed Moneycontrol videos.

Stock Market LIVE: Sensex, Nifty Off Day’s Lows | F&O Expiry Sparks Volatility | Closing Bell

‘Ashoka University Won’t Expand to Other Cities’ | Pramath Raj Sinha & Ashish Dhawan LIVE

Live: Nifty to test 26,000-mark on monthly expiry day | Opening Bell

LIVE: Moneycontrol Mutual Fund Summit 2025 |Bengaluru| Decoding Purpose, Products, Tech
You are already a Moneycontrol Pro user.

